Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 16 Results

Title
Intervention Indication Therapeutic Area Year Actions
Vorasidenib for treating residual or recurrent grade 2 glioma Vorasidenib Glioma Neurological Cancer 2023 View  |  Download
Toca 511 and Toca FC for Recurrent High Grade Glioma Toca-511 (vocimagene amiretrorepvec) , Toca-FC (flucytosine) Glioma Neurological Cancer 2018 View  |  Download
Selumetinib for treating symptomatic, inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in adults Selumetinib (AZD6244; ARRY-142886) Plexiform neurofibromas Neurological Cancer , Neurology 2023 View  |  Download
Phelinun for reduced intensity conditioning treatment prior to allogeneic haematopoietic stem cell transplantation Melphalan hydrochloride (Cydex; CDX-353; Phelinun) Acute myeloid leukaemia (AML) , Hodgkin lymphoma , Multiple myeloma (MM) , Neuroblastoma , Non-Hodgkin lymphoma (NHL) , Ovarian cancer Female Reproductive Cancer , Haematological Cancer and Lymphomas , Neurological Cancer 2021 View  |  Download
Nivolumab in addition to temozolomide and radiotherapy for MGMT-methylated glioblastoma in newly diagnosed adults - first line Nivolumab (Opdivo; BMS-936558; ONO-4538) , Radiation , Temozolomide (Temodar; Temodal; SCH 52365) Glioma Neurological Cancer 2019 View  |  Download
Nivolumab in addition to radiation therapy for glioblastoma – first line Nivolumab (Opdivo; BMS-936558; ONO-4538) , Radiation Glioma Neurological Cancer 2018 View  |  Download
Naxitamab in combination with granulocyte-macrophage colony stimulation factor for relapsed/refractory high-risk neuroblastoma Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF; GM-CSF vaccine) , Naxitamab (Hu3F8; Danyelza) Neuroblastoma Neurological Cancer 2020 View  |  Download
MTX-110 for newly-diagnosed diffuse intrinsic pontine glioma Panobinostat (MTX-110; Farydak; LBH589; LBH-589; panobinostat lactate anhydrous) Glioma Neurological Cancer 2019 View  |  Download
Lutetium oxodotreotide with octreotide for treating previously untreated advanced gastroenteropancreatic neuroendocrine tumour Lutetium oxodotreotide , Octreotide Gastroenteropancreatic neuroendocrine tumour Neurological Cancer 2023 View  |  Download
LAM-561 in addition to radiation therapy and temozolomide for glioblastoma –adjuvant 2-hydroxyoleic acid (2-OHOA; LP561A1; LAM561) , Radiotherapy , Temozolomide (Temodar; Temodal; SCH 52365) Glioma Neurological Cancer 2021 View  |  Download
1 2
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications